Biological Clustering of Pulmonary Exacerbations in CF (BIOPEX-CF), Canada

Registration Status: Completed

Objective: The purpose of study is to identify phenotypes of clinical pulmonary exacerbations and develop blood-based biomarkers of the phenotypes in cystic fibrosis adult patients. As such, samples collected through this study will be kept for future use in research.

Registered Biobank Name Biological Clustering of Pulmonary Exacerbations in CF (BIOPEX-CF)
Biobank Leader Kathryn Donohoe
Country Canada
Email for biobank inquiries kdonohue@providencehealth.bc.ca
Principal Investigator Bradley Quon
User Type
  • Mono: A biobank that supports a specific research project, may have few staff members, a small-scale accrual scope with little to no initial intention of releasing or distributing biospecimens to secondary parties
  • Oligo: A biobank that supports several research groups or clinical trials, may or may not be designed to release biospecimens outside their collaborative group
  • Poly: A biobank that has generally a larger accrual scope, resources, and multiple users outside the biobank proper
Biospecimen Collected: